| ACE2 is the critical in vivo receptor for SARS-CoV-2 in a novel COVID-19 mouse model with TNF-and IFNγ-driven immunopathology R Gawish, P Starkl, L Pimenov, A Hladik, K Lakovits, F Oberndorfer, ... Elife 11, e74623, 2022 | 53 | 2022 |
| PCprophet: a framework for protein complex prediction and differential analysis using proteomic data A Fossati, C Li, F Uliana, F Wendt, F Frommelt, P Sykacek, M Heusel, ... Nature methods 18 (5), 520-527, 2021 | 50 | 2021 |
| Structure-guided glyco-engineering of ACE2 for improved potency as soluble SARS-CoV-2 decoy receptor T Capraz, NF Kienzl, E Laurent, JW Perthold, E Föderl-Höbenreich, ... Elife 10, e73641, 2021 | 34 | 2021 |
| Randomly barcoded transposon mutant libraries for gut commensals I: Strategies for efficient library construction S Tripathi, CGP Voogdt, SO Bassler, M Anderson, PH Huang, ... Cell Reports 43 (1), 2024 | 6 | 2024 |
| Feature selection by replicate reproducibility and non-redundancy T Capraz, W Huber Bioinformatics 40 (9), btae548, 2024 | 4 | 2024 |
| Restraining Wnt activation and intestinal tumorigenesis by a Rab35 dependent GTPase relay S Redhai, T Wang, KE Boonekamp, S Reuter, T Capraz, S Leible, ... bioRxiv, 2024.02. 05.578891, 2024 | 1 | 2024 |
| Proteomic profiling identifies Serpin B9 as mediator of resistance to CAR T-cell and bispecific antibody treatment in B-cell lymphoma BJ Brinkmann, T Capraz, T Roider, M Knoll, C Kolb, Y Liu, ... bioRxiv, 2023.06. 26.546507, 2023 | 1 | 2023 |
| Semi-supervised Omics Factor Analysis (SOFA) disentangles known sources of variation from latent factors in multi-omics data T Capraz, H Vöhringer, W Huber bioRxiv, 2024.10. 10.617527, 2024 | | 2024 |
| PROTEOMIC PROFILING IDENTIFIES GRANZYME B INHIBITOR SERPIN B9 AS MEDIATOR OF RESISTANCE TO CAR T‐CELL AND BISPECIFIC ANTIBODY TREATMENT IN NODAL B‐CELL LYMPHOMA. BJ Brinkmann, T Roider, T Capraz, M Knoll, C Kolb, Y Liu, C Müller‐Tidow, ... Hematological Oncology 41, 2023 | | 2023 |
| ACE2 is the critical in vivo receptor for SARS-CoV-2 in a novel COVID-19 mouse model with TNF-and IFN?-driven immunopathology R Gawish, B Agerer, L Endler, T Capraz, JW Perthold, D Cikes, ... eLife Sciences Publications Limited, 0 | | |
